Adrian F Hernandez Selected Research

Patient Readmission

1/2021	Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial.
1/2021	Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis.
1/2020	Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial.
1/2020	The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper.
12/2019	Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.
9/2019	Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF.
1/2019	Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.
12/2018	Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission.
1/2018	Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.
1/2018	Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian F Hernandez Research Topics

Disease

293	Heart Failure 06/2022 - 01/2004
54	Stroke (Strokes) 01/2022 - 09/2009
40	Ischemic Stroke 01/2022 - 05/2010
37	Atrial Fibrillation 01/2022 - 08/2008
29	Myocardial Infarction 11/2022 - 10/2005
28	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2016
23	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2016
21	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2007
20	Dyspnea (Shortness of Breath) 11/2021 - 02/2009
17	Diabetes Mellitus 01/2020 - 03/2012
16	Hemorrhage 01/2021 - 11/2011
15	Venous Thromboembolism 01/2019 - 03/2014
12	Cardiomyopathies (Cardiomyopathy) 01/2022 - 05/2005
12	Left Ventricular Dysfunction 01/2020 - 12/2008
11	Chronic Renal Insufficiency 01/2022 - 08/2011
11	Renal Insufficiency (Renal Failure) 01/2019 - 10/2008
10	Hypotension (Low Blood Pressure) 01/2022 - 11/2010
10	Acute Coronary Syndrome 01/2022 - 12/2007
9	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 03/2012
7	Weight Loss (Weight Reduction) 01/2021 - 11/2010
7	Thrombosis (Thrombus) 01/2019 - 09/2010
7	ST Elevation Myocardial Infarction 06/2018 - 08/2009
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 06/2012
6	Coronary Disease (Coronary Heart Disease) 01/2022 - 09/2006
6	Hypertension (High Blood Pressure) 01/2021 - 09/2009
6	Fibrosis (Cirrhosis) 01/2021 - 01/2014
6	Transient Ischemic Attack 07/2015 - 09/2009
5	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 09/2006
5	Edema (Dropsy) 11/2021 - 11/2010
5	Cerebral Hemorrhage 01/2019 - 10/2010
5	Pulmonary Embolism 01/2018 - 03/2017
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 05/2011
4	COVID-19 10/2022 - 01/2020
4	Heart Diseases (Heart Disease) 01/2022 - 09/2016
4	Hyperkalemia 01/2022 - 06/2012
4	Vascular Diseases (Vascular Disease) 12/2021 - 08/2009
4	Anemia 11/2021 - 09/2009
4	Pneumonia (Pneumonitis) 10/2021 - 11/2013
4	Infections 10/2021 - 08/2015

Drug/Important Bio-Agent (IBA)

62	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 12/2007
29	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 12/2008
25	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 02/2011
24	Angiotensin Receptor AntagonistsIBA 01/2022 - 12/2008
23	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 08/2008
22	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2009
19	DiureticsIBA 11/2021 - 11/2010
19	Warfarin (Coumadin)FDA LinkGeneric 10/2019 - 02/2009
18	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 10/2016
17	Exenatide (Byetta)FDA Link 01/2022 - 04/2016
17	vericiguatIBA 01/2022 - 01/2018
16	Neprilysin (Neutral Endopeptidase)IBA 06/2022 - 01/2016
16	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2010
16	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 03/2013
15	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2022 - 09/2012
15	betrixabanIBA 04/2019 - 03/2014
14	CreatinineIBA 01/2022 - 09/2006
14	AnticoagulantsIBA 01/2022 - 11/2011
14	LipidsIBA 01/2019 - 08/2009
12	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019 - 11/2010
10	SodiumIBA 01/2022 - 01/2010
10	Enoxaparin (Lovenox)FDA LinkGeneric 04/2019 - 11/2016
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2019
8	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2014
7	Vitamin K FDA Link 01/2022 - 05/2012
7	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2020 - 03/2013
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 04/2008
7	fibrin fragment D (D-dimer)IBA 01/2019 - 03/2017
6	omega-Chloroacetophenone (Mace)IBA 01/2022 - 07/2015
6	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 07/2014
6	Pharmaceutical PreparationsIBA 01/2019 - 10/2010
6	TroponinIBA 12/2018 - 11/2012
6	Urea (Carbamide)FDA LinkGeneric 06/2017 - 01/2010
6	NitrogenIBA 06/2017 - 01/2010
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2019
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 01/2018
5	Soluble Guanylyl CyclaseIBA 10/2020 - 12/2009
5	Hydralazine (Apresoline)FDA LinkGeneric 12/2019 - 02/2009
5	RivaroxabanIBA 12/2019 - 07/2015
5	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 04/2016
5	Dabigatran FDA Link 10/2019 - 07/2015
4	Natriuretic PeptidesIBA 01/2022 - 09/2009
4	dapagliflozinIBA 01/2022 - 01/2020
4	Insulin (Novolin)FDA Link 01/2022 - 09/2006
4	apixabanIBA 01/2022 - 12/2016
4	Furosemide (Lasix)FDA LinkGeneric 11/2021 - 03/2011

Therapy/Procedure

140	Therapeutics 10/2022 - 01/2004
30	Patient Readmission 01/2021 - 04/2008
25	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 05/2005
20	Length of Stay 01/2019 - 12/2008
14	Cardiac Resynchronization Therapy 01/2022 - 08/2008
13	Heart-Assist Devices 10/2020 - 01/2004
10	Contraindications 01/2022 - 02/2009
9	Percutaneous Coronary Intervention 01/2022 - 08/2009
9	Secondary Prevention 01/2021 - 10/2007
8	Thrombolytic Therapy 01/2022 - 02/2014
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 08/2009
6	Heart Transplantation (Grafting, Heart) 01/2018 - 11/2005
5	Defibrillators (Defibrillator) 01/2022 - 11/2014
5	Drug Therapy (Chemotherapy) 12/2020 - 09/2012
4	Surgical Amputation (Amputations) 10/2021 - 01/2014